Literature DB >> 12112843

Identification of the phosphotyrosine proteome from thrombin activated platelets.

Patricia B Maguire1, Kieran J Wynne, Donal F Harney, Niaobh M O'Donoghue, Gillian Stephens, Desmond J Fitzgerald.   

Abstract

Signalling cascades are regulated both positively and negatively by tyrosine phosphorylation. Integrin mediated platelet adhesion triggers signal transduction cascades involving translocation of proteins and tyrosine phosphorylation events, ultimately causing large signalling complexes to be assembled. In resting platelets, a small number of phosphorylated proteins are evident with molecular mass of 50-62 kDa and 120-130 kDa. In thrombin activated human platelets, however, there is a large increase in the number of tyrosine phosphorylated signalling proteins detected. These proteins include pCas (130 kDa), FAK (125 kDa), PI(3)k (85 kDa) and src (85 kDa). However, it is unlikely that this list of proteins represents all the dynamic changes that occur after platelet activation and it is understood that more proteins remain unidentified. In this study, we propose a method for the isolation of the phosphotyrosine proteome from both resting and thrombin activated human platelets. All the dynamic phosphotyrosine events that occur in the platelet after thrombin activation were isolated by immunoprecipitation, using the monoclonal antibody 4G10, allowing us to obtain higher concentrations of relatively low abundant proteins. The resulting phosphotyrosine proteomes were separated by two-dimensional gel electrophoresis. Sixty-seven proteins were reproducibly found to be unique in the thrombin activated platelet proteome when compared to resting platelets. We have positively identified ten of these proteins by Western blotting and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry and these include FAK, Syk, ALK-4, P2X6 and MAPK kinase kinase. This proteomics approach to understanding the signalling events following platelet activation may elucidate potential drug targets for the treatment of coronary thrombosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112843     DOI: 10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  27 in total

Review 1.  Platelet genomics and proteomics in human health and disease.

Authors:  Iain C Macaulay; Philippa Carr; Arief Gusnanto; Willem H Ouwehand; Des Fitzgerald; Nicholas A Watkins
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 2.  Proteomic approaches to dissect platelet function: Half the story.

Authors:  Dmitri V Gnatenko; Peter L Perrotta; Wadie F Bahou
Journal:  Blood       Date:  2006-08-22       Impact factor: 22.113

Review 3.  Proteomics: applications in transfusion medicine.

Authors:  Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2008-04       Impact factor: 3.443

4.  Canonical Wnt signaling negatively regulates platelet function.

Authors:  Brian M Steele; Matthew T Harper; Iain C Macaulay; Craig N Morrell; Alita Perez-Tamayo; Martina Foy; Raymond Habas; Alastair W Poole; Desmond J Fitzgerald; Patricia B Maguire
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

5.  Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs.

Authors:  Özgün Babur; Alexander R Melrose; Jennifer M Cunliffe; John Klimek; Jiaqing Pang; Anna-Liisa I Sepp; Jevgenia Zilberman-Rudenko; Samuel Tassi Yunga; Tony Zheng; Iván Parra-Izquierdo; Jessica Minnier; Owen J T McCarty; Emek Demir; Ashok P Reddy; Phillip A Wilmarth; Larry L David; Joseph E Aslan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

6.  Global proteome analysis identifies active immunoproteasome subunits in human platelets.

Authors:  Cordula Klockenbusch; Geraldine M Walsh; Lyda M Brown; Michael D Hoffman; Vladimir Ignatchenko; Thomas Kislinger; Juergen Kast
Journal:  Mol Cell Proteomics       Date:  2014-08-21       Impact factor: 5.911

7.  Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release.

Authors:  Sybille Rex; Lea M Beaulieu; David H Perlman; Olga Vitseva; Price S Blair; Mark E McComb; Catherine E Costello; Jane E Freedman
Journal:  Thromb Haemost       Date:  2009-07       Impact factor: 5.249

8.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12

9.  Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling.

Authors:  Amir H Qureshi; Vineet Chaoji; Dony Maiguel; Mohd Hafeez Faridi; Constantinos J Barth; Saeed M Salem; Mudita Singhal; Darren Stoub; Bryan Krastins; Mitsunori Ogihara; Mohammed J Zaki; Vineet Gupta
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

10.  Early cellular signaling responses to axonal injury.

Authors:  Thomas J Lukas; Ai Ling Wang; Ming Yuan; Arthur H Neufeld
Journal:  Cell Commun Signal       Date:  2009-03-13       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.